Chiasma
$3.76
12
-$0.24-6% Thursday 20:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
217.68M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
4MayExpected
Expected EPS
N/A
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow CHMA. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Health Technology
Biotechnology
Manufacturing
Pharmaceutical Preparation Manufacturing
Chiasma, Inc., a clinical late-stage biopharmaceutical company, focuses on developing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company develops oral octreotide capsules for adult patients under the MYCAPSSA name, which is in Phase III clinical trials for the treatment of acromegaly, a condition that results in the body's production of excess growth hormone. Chiasma, Inc. was founded in 2001 and is headquartered in Needham, Massachusetts.
Show more...
CEO
Raj Kannan
Employees
84
Country
US
Listings
0 Comments
Share your thoughts
FAQ
What is Chiasma stock price today?▼
The current price of CHMA is $3.76 USD — it has decreased by -6% in the past 24 hours. Watch Chiasma stock price performance more closely on the chart.
What is Chiasma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Chiasma stocks are traded under the ticker CHMA.
What is Chiasma market cap?▼
Today Chiasma has the market capitalization of 217.68M
How many employees does Chiasma have?▼
As of April 03, 2026, the company has 84 employees.
In which sector is Chiasma located?▼
Chiasma operates in the Manufacturing sector.
When did Chiasma complete a stock split?▼
Chiasma has not had any recent stock splits.
Where is Chiasma headquartered?▼
Chiasma is headquartered in Needham, US.